09 May2024Approximately USD 10.8 Million Invested in New Drug Development for Malaria and NTDs in Partners Including Japanese Pharma Shionogi, Mitsubishi Tanabe, and Eisai and Europe-Based InstitutionsAuthor By Healthufit Posted on May 9, 2024May 9, 2024Approximately USD 10.8 Million Invested in New Drug Development for Malaria...
19 Mar2024LifeSpan Vision Ventures Invests In SENISCAAuthor By Healthufit Posted on March 19, 2024March 19, 2024LifeSpan Vision Ventures Invests In SENISCA LifeSpan Vision Ventures, an...